Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P220024/S007

LIQUIFIX FIX8 Laparoscopic Hernia Mesh Fixation (HMF) Device; LIQUIFIX Precision Open Hernia Mesh Fixation Device

Advanced Medical Solutions Limited · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONP220024/S007

What did the FDA approve?

The FDA record for P220024/S007 describes a normal 180-day-track supplement without user fee, filed under the postapproval study protocol reason for Advanced Medical Solutions Limited's LIQUIFIX FIX8 laparoscopic hernia mesh fixation device and LIQUIFIX Precision open hernia mesh fixation device. According to the source statement, the approval covers a revised LIQUFIX Post-Approval Study protocol intended to address patient enrollment issues by combining the laparoscopic and open devices into a single body of evidence and revising patient sample sizes for both devices.

The identifier ties this action to the original PMA P220024; the statement says the PAS protocol was submitted to comply with conditions of approval in that approval order. This supplement is not a new approval of the whole system, and the stated purpose of the protocol change is not independent proof of safety or clinical effectiveness. The supplied fields do not specify the revised sample sizes, enrollment targets, endpoints, or timelines.

FDA approval order statement

approval of the revised protocol to address patient enrollment issues associated with the LIQUFIX Post-Approval Study (PAS). The changes are, namely, the combining the laparoscopic and open devices into a single body of evidence and to revising the patient sample sizes for both devices. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P220024.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
General, Plastic Surgery
Decision date
Oct 23, 2026
FDA change category
Postapproval Study Protocol

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P220024/S007
Regulatory pathway
PMA supplement
Product code
PLJ
Decision code
APPR
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Tissue adhesive internal use.

Product code
PLJ
FDA device class
3

For the original device and its historical approval scope, see PMA P220024. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P220024 · Original PMA

    LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device, LIQUIFIX Precision Open Hernia Mesh Fixation Device

  2. P220024/S007 received

    Application receipt date recorded by FDA.

  3. P220024/S007 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P220024. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220024

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Advanced Medical Solutions Limited

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Western Wood Way, Langage Science Park, Plymouth, PL7 5BG

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records